Contact SRI Biosciences

SRI Biosciences

SRI Biosciences provides complete drug and biologic discovery and development capabilities to take drugs from Idea to IND™. Learn how SRI can help you move your lead compound from the lab bench to the clinic by clicking on the topics in the diagram below, in the links at left, or on our detailed site map.

What's New   SRI International and F. Hoffmann-La Roche Launch Translational Medicine Collaboration to Study Methods and Treatments Associated with Cognitive Deficits across Neuropsychiatric Disorders     SRI International and Regional and State Leaders Dedicate New SRI Shenandoah Valley Facility in Harrisonburg, Virginia     SRI International Awarded a Department of Defense "Laboratory-Clinical Transition" Grant to Advance SRI’s Novel Anticancer Agents for Prostate Cancer Treatment     SRI SRI Awarded National Institute of Mental Health Contract for Evaluation of Brain Imaging Agents and Medications for Treatment of Mental Disorders     FDA Approves Pralatrexate for Treatment of Peripheral T-Cell Lymphoma; Drug Discovered and Developed by SRI International, Memorial Sloan-Kettering Cancer Center, and Southern Research Institute                   Trade Shows and Presentations     CACO-BAADME Joint Workshop Foster City, CA, December 8     American Society of Tropical Medicine and Hygiene (ASTMH) Annual Meeting and Exposition Washington, DC, November 18-22

SRI Biosciences is a unique organization of approximately 230 people with all of the resources necessary to take chemical and biological research programs from Idea to IND™— from initial discoveries to investigational new drug applications to start human clinical trials. The Biosciences Division performs basic research on disease mechanisms like an academic institution; drug discovery and the development of biologics like a biotechnology or pharmaceutical company; and full-service preclinical contract research and development like a CRO (contract research organization).  

SRI has been providing industry leaders, emerging companies, and government agencies with a broad range of pharmaceutical discovery and development capabilities since the 1950s. Our clients and partners have long benefited from the multidisciplinary expertise of our technical staff, strict adherence to regulatory guidelines, and the convenience of having all our resources at one location.

Contact SRI Biosciences

Last Updated Nov 18, 2009